Photo by Michael Nigro/Sipa USA

SCOTUS rejects anti-rights attempt to sideline mifepristone

Today the U.S. Supreme Court rejected the anti-abortion case brought by the Alliance for Hippocratic Medicine against the Food and Drug Administration (FDA), ensuring that mifepristone will remain available.

The case sought to reverse the FDA’s approval of the medication abortion drug, mifepristone, based on false claims that the drug is unsafe.  While the Court’s unanimous decision held that the plaintiffs had no standing and underscores the importance of evidenced-based abortion care, it is only a minor victory in a major fight to protect reproductive freedom in the United States.

“Abortion with pills is a safe and effective way to end an unwanted or unintended pregnancy. It is unconscionable that a group of anti-rights, extremist organizations and doctors are intent on erasing access to an essential health-care service. Abortion is health care and it’s a human right. All people have the right to control their own body and health, and to determine their own future. And this means being able to have an abortion,” says Anu Kumar, Ipas President and CEO.

This case challenging mifepristone is just one piece of a relentless strategy by anti-rights actors to ban abortion nationwide, deny rights, and, essentially, dismantle democracy.

The ruling comes just before the anniversary of the Dobbs decision that overturned Roe v. Wade, a decision that opened the door for 14 states to ban abortion completely and threatens the health and safety of pregnant people—and their families—each day in the United States.

As a global reproductive justice organization, Ipas is dedicated to expanding access to abortion and contraception for all who need it. We will continue to advocate for access to safe, legal abortion because we believe everyone, no matter who they are or where they live, should be able to determine their own future.

For more information contact: [email protected]